Candriam Luxembourg S.C.A. Buys New Position in Mazor Robotics Ltd. (MZOR)
Candriam Luxembourg S.C.A. purchased a new position in shares of Mazor Robotics Ltd. (NASDAQ:MZOR) during the second quarter, Holdings Channel reports. The institutional investor purchased 60,000 shares of the company’s stock, valued at approximately $1,079,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Trellus Management Company LLC increased its position in shares of Mazor Robotics by 11.6% in the second quarter. Trellus Management Company LLC now owns 23,982 shares of the company’s stock worth $431,000 after buying an additional 2,500 shares during the last quarter. Menta Capital LLC increased its position in shares of Mazor Robotics by 81.9% in the first quarter. Menta Capital LLC now owns 37,482 shares of the company’s stock worth $466,000 after buying an additional 16,879 shares during the last quarter. Finally, Iguana Healthcare Management LLC increased its position in shares of Mazor Robotics by 384.6% in the first quarter. Iguana Healthcare Management LLC now owns 121,151 shares of the company’s stock worth $1,507,000 after buying an additional 96,151 shares during the last quarter. 18.71% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Mazor Robotics Ltd. (NASDAQ:MZOR) traded down 3.93% during mid-day trading on Thursday, reaching $22.71. The company’s stock had a trading volume of 372,079 shares. The firm’s market cap is $492.19 million. The firm’s 50-day moving average price is $23.23 and its 200 day moving average price is $17.83. Mazor Robotics Ltd. has a 12-month low of $8.31 and a 12-month high of $26.48.
Mazor Robotics (NASDAQ:MZOR) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported ($0.09) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.11) by $0.02. The firm earned $8.30 million during the quarter, compared to analysts’ expectations of $8.51 million. Mazor Robotics had a negative return on equity of 42.30% and a negative net margin of 60.75%. The business’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the firm earned ($0.05) EPS. On average, analysts expect that Mazor Robotics Ltd. will post ($0.71) EPS for the current year.
MZOR has been the topic of a number of research analyst reports. Standpoint Research initiated coverage on Mazor Robotics in a report on Friday, July 8th. They set a “buy” rating and a $30.00 price target on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Mazor Robotics in a research report on Thursday, July 7th. Zacks Investment Research upgraded Mazor Robotics from a “sell” rating to a “hold” rating in a research report on Tuesday, June 14th. B. Riley initiated coverage on Mazor Robotics in a research report on Thursday. They set a “neutral” rating and a $25.00 price objective for the company. Finally, Barclays PLC upped their price objective on Mazor Robotics from $16.00 to $23.00 and gave the company an “overweight” rating in a research report on Thursday, July 14th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Mazor Robotics currently has a consensus rating of “Hold” and an average price target of $25.00.
Mazor Robotics Company Profile
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.
Want to see what other hedge funds are holding MZOR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mazor Robotics Ltd. (NASDAQ:MZOR).
Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.